View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
July 14, 2022

Signant Health unveils updates to trial supply management platform

The company has collaborated with courier providers for ‘last mile’ deliveries to the homes of patients.

Signant Health has announced improvements to its Randomization and Trial Supply Management (RTSM) platform for delivery of clinical supplies to patients’ homes directly.

Signant SmartSignals RTSM will enable customers to leverage additional digitally optimised trial benefits.

The enhancements to the platform enable secure, convenient, and encrypted information storage related to shipment addresses of patients, integration with depot/central pharmacy ordering systems, and reporting of courier status.

This ensures transparent and simple medication provisioning to the patient directly with complete investigator oversight.  

Signant Health RTSM product management director Bart Nicholson said: “The lack of comprehensive, RTSM-driven approaches to direct-to-patient medication delivery has slowed uptake of this important aspect of trial optimisation.

“We worked closely with customers and other stakeholders to develop a solution that solves critical issues essential for a successful, technology-enabled, direct-to-patient experience.

“Simplifying processes for sites, ensuring full sponsor oversight of the medication chain of custody, and maintaining investigator dosing authority are critical components we have comprehensively addressed with this latest release.”

Additionally, the company has collaborated with courier providers for ‘last mile’ clinical supply deliveries to the homes of patients, thereby eliminating the need for manual steps.

With Signant SmartSignals RTSM, investigators and sponsors will have complete visibility of the medication chain of custody for all steps in the process.  

The Signant SmartSignals RTSM-powered direct-to-patient supply management is now available and can be applied to a range of clinical trials.

Last month, Signant Health announced new advancements in its electronic Clinical Outcomes Assessment (eCOA) software, Signant SmartSignals eCOA, to address trial sponsors and contract research organisations’ requirements.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Clinical Trials Arena